awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44951134-6EC8F8EB-6308-42F1-B2D4-F79B5046CA8A
Q44951134-6EC8F8EB-6308-42F1-B2D4-F79B5046CA8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44951134-6EC8F8EB-6308-42F1-B2D4-F79B5046CA8A
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.
P2860
Q44951134-6EC8F8EB-6308-42F1-B2D4-F79B5046CA8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44951134-6EC8F8EB-6308-42F1-B2D4-F79B5046CA8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fef26774b1c8b4e5c842a5e1b4b5593a4c95689f
P2860
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo